Skip to main content
Top
Published in: BMC Ophthalmology 1/2016

Open Access 01-12-2016 | Research article

Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia

Authors: Tesfay Mehari, Abeba T. Giorgis, Workineh Shibeshi

Published in: BMC Ophthalmology | Issue 1/2016

Login to get access

Abstract

Background

Good adherence to ocular hypotensive agents is important to control intraocular pressure and hence to prevent progressive glaucomatous optic nerve head damage. Periodic investigation of adherence is crucial in glaucoma treatment. The purpose of this study was to assess level of adherence to ocular hypotensive agents and to identify factors affecting adherence among glaucoma patients at a tertiary public eye care center.

Methods

The study was a hospital-based cross-sectional study that was conducted in Menelik II Referral Hospital from June 1, 2015 to July 31, 2015. A systematic random sampling technique was used to select 359 study participants from the source population. The study patients were interviewed and their medical charts were reviewed using a pretested structured questionnaire. Adherence was assessed using Morisky Medication Adherence Scale - 8 and adherence determinant factors were identified using multivariate binary logistic regression analysis. The association was declared statistically significant at p < 0.05.

Results

Among the 359 study glaucoma patients, 42.6 % were adherent to their prescribed hypotensive agents. Higher educational level (AOR = 4.60, 95 % CI: 1.01–21.03, p < 0.049), being self - employed (AOR = 6.14, 95 % CI: 1.37–27.50, p < 0.018) and taking lesser frequency of drops (AOR = 2.89, 95 % CI: 1.25–6.66, p < 0.013) were significantly associated with adherence, whereas being a farmer (AOR = 0.07, 95 % CI: 0.01–0.75, p < 0.028), having very low monthly family income (AOR = 0.22, 95 % CI: 0.06–0.77, p < 0.019) and self - purchasing of medications (AOR = 0.30, 95 % CI: 0.10–0.93, p < 0.036) were significantly associated with non-adherence.

Conclusions

The study has identified the adherence level to the prescribed ocular hypotensive agents to be sub-optimal and is influenced by different factors among glaucoma patients of the public tertiary center. We recommend glaucoma care providers to pay due attention on the importance of adherence.
Literature
1.
go back to reference McVeigh KA, Vakros G. The eye drop chart: A pilot study for improving administration of and compliance with topical treatments in glaucoma patients. Clin Ophthalmol. 2015;9:813–9.PubMedPubMedCentral McVeigh KA, Vakros G. The eye drop chart: A pilot study for improving administration of and compliance with topical treatments in glaucoma patients. Clin Ophthalmol. 2015;9:813–9.PubMedPubMedCentral
2.
go back to reference Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;21:2081–90.CrossRef Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;21:2081–90.CrossRef
3.
go back to reference Kyari F, Abdull MM, Bastawrous A, Gilbert CE, Faal H. Epidemiology of glaucoma in sub-Saharan Africa: prevalence, incidence and risk factors. Middle East Afr J Ophthalmol. 2013;20:111–25.CrossRefPubMedPubMedCentral Kyari F, Abdull MM, Bastawrous A, Gilbert CE, Faal H. Epidemiology of glaucoma in sub-Saharan Africa: prevalence, incidence and risk factors. Middle East Afr J Ophthalmol. 2013;20:111–25.CrossRefPubMedPubMedCentral
4.
go back to reference Alemu AM, Nelson LA, Kruft B, Stewart JA, Stewart WC. Epidemiology of glaucoma in central Ethiopia. Int J Ophthalmol. 2009;2:168–73. Alemu AM, Nelson LA, Kruft B, Stewart JA, Stewart WC. Epidemiology of glaucoma in central Ethiopia. Int J Ophthalmol. 2009;2:168–73.
5.
go back to reference World Health Organization (WHO). Adherence to long-term therapies. Evidence for action. Geneva: World Health Organization; 2003. World Health Organization (WHO). Adherence to long-term therapies. Evidence for action. Geneva: World Health Organization; 2003.
6.
go back to reference Lee PP, Walt JW, Rosenblatt LC, Siegartel LR, Stern LS. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review. Am J Ophthalmol. 2007;144:901–7.CrossRefPubMed Lee PP, Walt JW, Rosenblatt LC, Siegartel LR, Stern LS. Association between intraocular pressure variation and glaucoma progression: data from a United States chart review. Am J Ophthalmol. 2007;144:901–7.CrossRefPubMed
7.
go back to reference Robert NW, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311:1901–11.CrossRef Robert NW, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311:1901–11.CrossRef
8.
go back to reference Tsai T, Robin AL, Smith JP. An evaluation of how glaucoma patients use topical medications: a pilot study. Trans Am Ophthalmol Soc. 2007;105:29–35.PubMedPubMedCentral Tsai T, Robin AL, Smith JP. An evaluation of how glaucoma patients use topical medications: a pilot study. Trans Am Ophthalmol Soc. 2007;105:29–35.PubMedPubMedCentral
9.
go back to reference Schwartz GF. Adherence and persistence in glaucoma. In: Grehn F, Stamper R, editors. Glaucoma. Berlin: Heidelberg Platz; 2006. p. 91–105.CrossRef Schwartz GF. Adherence and persistence in glaucoma. In: Grehn F, Stamper R, editors. Glaucoma. Berlin: Heidelberg Platz; 2006. p. 91–105.CrossRef
10.
go back to reference Olthoff CM, Schouten JS, van de Borne B, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence - based review. Ophthalmology. 2005;112:953–61.CrossRefPubMed Olthoff CM, Schouten JS, van de Borne B, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence - based review. Ophthalmology. 2005;112:953–61.CrossRefPubMed
11.
go back to reference Lu VH, Goldberg I, Lu CY. Use of glaucoma medications: State of the science and directions for observational research. Am J Ophthalmol. 2010;150:569–74.CrossRefPubMed Lu VH, Goldberg I, Lu CY. Use of glaucoma medications: State of the science and directions for observational research. Am J Ophthalmol. 2010;150:569–74.CrossRefPubMed
12.
go back to reference Konstas AGP, Maskaleris G, Gratsonidis S, Sardelli C. Compliance and viewpoint of glaucoma patients in Greece. Eye. 2000;14:752–6.CrossRefPubMed Konstas AGP, Maskaleris G, Gratsonidis S, Sardelli C. Compliance and viewpoint of glaucoma patients in Greece. Eye. 2000;14:752–6.CrossRefPubMed
13.
go back to reference Stewart WC, Konstas AGP, Pfeiffer N. Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocular Pharmacol Ther. 2004;20:461–9.CrossRef Stewart WC, Konstas AGP, Pfeiffer N. Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment. J Ocular Pharmacol Ther. 2004;20:461–9.CrossRef
14.
go back to reference Gupta R, Patil B, Shah BM, Bali SJ, Mishra SK, Dada T. Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma. 2012;21:189–92.CrossRefPubMed Gupta R, Patil B, Shah BM, Bali SJ, Mishra SK, Dada T. Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma. 2012;21:189–92.CrossRefPubMed
15.
go back to reference Reeder CE, Franklin M, Bramley TJ. Managed care and the impact of glaucoma. Am J Manag Care. 2008;14:5–10. Reeder CE, Franklin M, Bramley TJ. Managed care and the impact of glaucoma. Am J Manag Care. 2008;14:5–10.
16.
go back to reference Kulkarni SV, Damji KF, Buys YM. Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency. Patient Prefer Adherence. 2008;2:303–14.CrossRefPubMedPubMedCentral Kulkarni SV, Damji KF, Buys YM. Medical management of primary open-angle glaucoma: Best practices associated with enhanced patient compliance and persistency. Patient Prefer Adherence. 2008;2:303–14.CrossRefPubMedPubMedCentral
17.
go back to reference Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive Validity of a Medication Adherence Measure in an Outpatient Setting. J Clin Hypertens. 2008;10:384–54.CrossRef Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive Validity of a Medication Adherence Measure in an Outpatient Setting. J Clin Hypertens. 2008;10:384–54.CrossRef
18.
go back to reference Daniel WW, Cross LC. Biostatistics: A foundation for analysis in the health sciences. 8th ed. Hoboken, New Jersey: John Wiley and Sons Inc; 2005. p. 158–65. Daniel WW, Cross LC. Biostatistics: A foundation for analysis in the health sciences. 8th ed. Hoboken, New Jersey: John Wiley and Sons Inc; 2005. p. 158–65.
19.
go back to reference Pedersini R, Vietri J. Comparison of the 4 - item and 8 - item Morisky Medication Adherence Scale in patients with type 2 diabetes. Kantar Health: Montreal; 2014. Pedersini R, Vietri J. Comparison of the 4 - item and 8 - item Morisky Medication Adherence Scale in patients with type 2 diabetes. Kantar Health: Montreal; 2014.
20.
go back to reference Muntner P, Joyce C, Holt E, He J, Morisky D, Webber LS, et al. Defining the minimal detectable change in scores on the eight - item Morisky Medication Adherence Scale. Ann Pharmacother. 2011;45:569–75.CrossRefPubMed Muntner P, Joyce C, Holt E, He J, Morisky D, Webber LS, et al. Defining the minimal detectable change in scores on the eight - item Morisky Medication Adherence Scale. Ann Pharmacother. 2011;45:569–75.CrossRefPubMed
21.
go back to reference LeBlanc R. Canadian Glaucoma Strategy Forum. A Canadian glaucoma strategy. Can J Ophthalmol. 2007;42:60–5.CrossRefPubMed LeBlanc R. Canadian Glaucoma Strategy Forum. A Canadian glaucoma strategy. Can J Ophthalmol. 2007;42:60–5.CrossRefPubMed
22.
go back to reference International Council of Ophthalmology (ICO). Visual Standards: Aspects and Ranges of Vision Loss. Sydney: International Council of Ophthalmology; 2002. International Council of Ophthalmology (ICO). Visual Standards: Aspects and Ranges of Vision Loss. Sydney: International Council of Ophthalmology; 2002.
23.
go back to reference Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, et al. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology. 2009;116:191–9.CrossRefPubMed Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, et al. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study. Ophthalmology. 2009;116:191–9.CrossRefPubMed
24.
go back to reference Stryker JE, Beck AD, Primo SA, Echt KV, Bundy L, Pretorius GC, et al. An exploratory study of factors influencing glaucoma treatment adherence. J Glaucoma. 2010;19:66–72.CrossRefPubMedPubMedCentral Stryker JE, Beck AD, Primo SA, Echt KV, Bundy L, Pretorius GC, et al. An exploratory study of factors influencing glaucoma treatment adherence. J Glaucoma. 2010;19:66–72.CrossRefPubMedPubMedCentral
25.
go back to reference Sleath B, Blalock S, Covert D, Stone JL, Skinner AC, Muir K, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011;118:2398–402.CrossRefPubMedPubMedCentral Sleath B, Blalock S, Covert D, Stone JL, Skinner AC, Muir K, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011;118:2398–402.CrossRefPubMedPubMedCentral
26.
go back to reference Kholdebarin R, Campbell RJ, Jin YP, Buys YM. Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol. 2008;43:454–61.CrossRefPubMed Kholdebarin R, Campbell RJ, Jin YP, Buys YM. Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol. 2008;43:454–61.CrossRefPubMed
27.
go back to reference Olthoff CM, Hoevenaars JG, van de Borne B, Webers CA, Schouten JS. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2009;247:235–43.CrossRefPubMed Olthoff CM, Hoevenaars JG, van de Borne B, Webers CA, Schouten JS. Prevalence and determinants of non-adherence to topical hypotensive treatment in Dutch glaucoma patients. Graefes Arch Clin Exp Ophthalmol. 2009;247:235–43.CrossRefPubMed
28.
go back to reference Richardson C, Brunton L, Olleveant N, Henson DB, Pilling M, Mottershead J, et al. A study to assess the feasibility of undertaking a randomized controlled trial of adherence with eye drops in glaucoma patients. Patient Prefer Adherence. 2013;7:1025–39.CrossRefPubMedPubMedCentral Richardson C, Brunton L, Olleveant N, Henson DB, Pilling M, Mottershead J, et al. A study to assess the feasibility of undertaking a randomized controlled trial of adherence with eye drops in glaucoma patients. Patient Prefer Adherence. 2013;7:1025–39.CrossRefPubMedPubMedCentral
29.
30.
go back to reference Boland MV, Chang DS, Frazier T, Plyler R, Friedman DS. Electronic monitoring to assess adherence with once - daily glaucoma medications and risk factors for nonadherence: The automated dosing reminder study. JAMA Ophthalmol. 2014;132:839–44. Boland MV, Chang DS, Frazier T, Plyler R, Friedman DS. Electronic monitoring to assess adherence with once - daily glaucoma medications and risk factors for nonadherence: The automated dosing reminder study. JAMA Ophthalmol. 2014;132:839–44.
32.
go back to reference Welge-lussen U, Weis S, Yu AL. Assessing the adherence behavior of glaucoma patients to topical eye drops. Patient Prefer Adherence. 2015;18:17–23. Welge-lussen U, Weis S, Yu AL. Assessing the adherence behavior of glaucoma patients to topical eye drops. Patient Prefer Adherence. 2015;18:17–23.
33.
go back to reference Friedman DS, Okeke CO, Jampel HD, Ying GS, Plyler RJ, Jiang Y, et al. Risk factors for poor adherence to eye drops in electronically monitored patients with glaucoma. Ophthalmology. 2009;116:1097–105.CrossRefPubMed Friedman DS, Okeke CO, Jampel HD, Ying GS, Plyler RJ, Jiang Y, et al. Risk factors for poor adherence to eye drops in electronically monitored patients with glaucoma. Ophthalmology. 2009;116:1097–105.CrossRefPubMed
34.
go back to reference Ung C, Murakarui Y, Zhang E, Alfaro T, Zhang M, Seider MI, et al. Glaucoma severity and medication adherence in a county hospital population. Ophthalmology. 2013;120:1150–147.CrossRefPubMedPubMedCentral Ung C, Murakarui Y, Zhang E, Alfaro T, Zhang M, Seider MI, et al. Glaucoma severity and medication adherence in a county hospital population. Ophthalmology. 2013;120:1150–147.CrossRefPubMedPubMedCentral
35.
go back to reference Hoevenaars JG, Schouten JS, van den Borne B, Beckers HJ, Webers CA. Will improvement of knowledge lead to improvement of compliance with glaucoma medication? Acta Ophthalmol. 2008;86:849–55.CrossRefPubMed Hoevenaars JG, Schouten JS, van den Borne B, Beckers HJ, Webers CA. Will improvement of knowledge lead to improvement of compliance with glaucoma medication? Acta Ophthalmol. 2008;86:849–55.CrossRefPubMed
Metadata
Title
Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia
Authors
Tesfay Mehari
Abeba T. Giorgis
Workineh Shibeshi
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2016
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-016-0316-z

Other articles of this Issue 1/2016

BMC Ophthalmology 1/2016 Go to the issue